GDC-0834
≥98%
- Product Code: 100608
CAS:
1133432-50-4
| Molecular Weight: | 596.753 g./mol | Molecular Formula: | C₃₃H₃₆N₆O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
GDC-0834 is primarily investigated for its potential in cancer therapy, specifically targeting Bruton's tyrosine kinase (BTK). This enzyme plays a critical role in B-cell development and signaling, making it a key target for treating B-cell malignancies like chronic lymphocytic leukemia and non-Hodgkin lymphoma. By inhibiting BTK, GDC-0834 aims to disrupt the survival and proliferation of cancerous B-cells, offering a targeted approach to therapy. Its application is particularly significant in cases where traditional treatments have limited efficacy or are not well-tolerated. Research continues to explore its effectiveness and potential use in combination with other therapies to enhance treatment outcomes.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Brown To Reddish Brown Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft127,026.73 |
+
-
|
GDC-0834
GDC-0834 is primarily investigated for its potential in cancer therapy, specifically targeting Bruton's tyrosine kinase (BTK). This enzyme plays a critical role in B-cell development and signaling, making it a key target for treating B-cell malignancies like chronic lymphocytic leukemia and non-Hodgkin lymphoma. By inhibiting BTK, GDC-0834 aims to disrupt the survival and proliferation of cancerous B-cells, offering a targeted approach to therapy. Its application is particularly significant in cases where traditional treatments have limited efficacy or are not well-tolerated. Research continues to explore its effectiveness and potential use in combination with other therapies to enhance treatment outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :